Sildenafil citrate (VIAGRA®): Analysis of preferred doses in a European, six-month, double-blind, placebo-controlled, flexible dose-escalation study in patients with erectile dysfunction

International Journal of Clinical Practice, Supplement

Volumn , Issue 102, 1999, Pages 27-29

  Hartmann, U ^a   Meuleman, E J H ^a   Cuzin, B ^a   Emrich, H M ^a   Declercq, G A ^a   Bailey, M J ^a   Maytom, M C ^a   Smith, M D ^a   Osterloh, I H ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; SILDENAFIL; PHOSPHODIESTERASE INHIBITOR; PIPERAZINE DERIVATIVE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMOGRAPHY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG TOLERANCE; DYSPEPSIA; ERECTILE DYSFUNCTION; EUROPE; FLUSHING; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT INFECTION; RHINITIS; VISUAL DISORDER; ADOLESCENT; IMPOTENCE; MIDDLE AGED; MULTICENTER STUDY; PATIENT SATISFACTION;

ADOLESCENT; DOUBLE-BLIND METHOD; HUMANS; IMPOTENCE; MALE; MIDDLE AGED; PATIENT SATISFACTION; PHOSPHODIESTERASE INHIBITORS; PIPERAZINES;

EID: 0033138438     PISSN: 1368504X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)